title: Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study).
authors.affiliation: Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA. Fmesserli@aol.com
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
authors.forename: Mandeep R
authors.initials: MR
authors.lastname: Mehra
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000150:complications*; D019808:Losartan / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
chemical_list: D000959:Antihypertensive Agents; D019808:Losartan